Peter R. Gibson

15.6k total citations · 6 hit papers
205 papers, 10.6k citations indexed

About

Peter R. Gibson is a scholar working on Genetics, Gastroenterology and Epidemiology. According to data from OpenAlex, Peter R. Gibson has authored 205 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Genetics, 82 papers in Gastroenterology and 77 papers in Epidemiology. Recurrent topics in Peter R. Gibson's work include Microscopic Colitis (71 papers), Inflammatory Bowel Disease (65 papers) and Gastrointestinal motility and disorders (49 papers). Peter R. Gibson is often cited by papers focused on Microscopic Colitis (71 papers), Inflammatory Bowel Disease (65 papers) and Gastrointestinal motility and disorders (49 papers). Peter R. Gibson collaborates with scholars based in Australia, United States and United Kingdom. Peter R. Gibson's co-authors include Susan Shepherd, Jane G. Muir, Jessica R. Biesiekierski, Jacqueline S. Barrett, Daniel R. van Langenberg, Evan Newnham, Ourania Rosella, Peter M. Irving, Chu K Yao and Simone Peters and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Peter R. Gibson

199 papers receiving 10.4k citations

Hit Papers

Subcutaneous Golimumab Induces Clinical Response and Remi... 2011 2026 2016 2021 2013 2013 2013 2011 2018 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter R. Gibson Australia 52 4.6k 3.9k 3.7k 3.0k 1.7k 205 10.6k
Peter M. Irving United Kingdom 52 3.5k 0.8× 3.8k 1.0× 2.4k 0.7× 2.2k 0.7× 1.7k 1.0× 337 9.1k
Salvatore Cucchiara Italy 58 4.3k 0.9× 4.3k 1.1× 3.3k 0.9× 5.3k 1.8× 761 0.4× 379 13.1k
Martti Färkkilâ Finland 59 2.2k 0.5× 3.2k 0.8× 5.3k 1.5× 5.0k 1.7× 936 0.5× 447 14.1k
Ruggiero Francavilla Italy 53 3.2k 0.7× 1.1k 0.3× 2.3k 0.6× 2.5k 0.8× 1.0k 0.6× 245 10.0k
Bernard Flourié France 52 1.9k 0.4× 3.1k 0.8× 1.7k 0.5× 2.4k 0.8× 1.2k 0.7× 219 8.0k
Kevin Whelan United Kingdom 61 5.1k 1.1× 2.9k 0.7× 1.5k 0.4× 2.8k 0.9× 3.9k 2.2× 290 13.6k
Roberto De Giorgio Italy 70 9.8k 2.1× 1.1k 0.3× 2.5k 0.7× 7.1k 2.4× 2.8k 1.6× 439 17.3k
Lena Öhman Sweden 46 3.5k 0.8× 1.4k 0.4× 1.3k 0.3× 1.7k 0.6× 1.4k 0.8× 182 7.8k
Carolina Ciacci Italy 51 7.1k 1.5× 1.5k 0.4× 4.8k 1.3× 4.3k 1.5× 327 0.2× 234 9.9k
Marjorie M. Walker Australia 54 4.5k 1.0× 880 0.2× 2.1k 0.6× 4.0k 1.3× 788 0.5× 244 9.4k

Countries citing papers authored by Peter R. Gibson

Since Specialization
Citations

This map shows the geographic impact of Peter R. Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter R. Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter R. Gibson more than expected).

Fields of papers citing papers by Peter R. Gibson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter R. Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter R. Gibson. The network helps show where Peter R. Gibson may publish in the future.

Co-authorship network of co-authors of Peter R. Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of Peter R. Gibson. A scholar is included among the top collaborators of Peter R. Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter R. Gibson. Peter R. Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Varney, Jane, Daniel So, Peter R. Gibson, et al.. (2025). Clinical Trial: Effect of a 28‐Day Low FODMAP Diet on Gastrointestinal Symptoms Associated With Endometriosis (EndoFOD)—A Randomised, Controlled Crossover Feeding Study. Alimentary Pharmacology & Therapeutics. 61(12). 1889–1903. 3 indexed citations
3.
Yao, Chu K, Jasjot Maggo, Emma P. Halmos, et al.. (2025). Telemetric Assessment and Comparison of Regional Colonic Metabolic Activity in Ambulant Healthy Individuals Using pH and Gas‐Sensing Wireless Motility Capsules. Alimentary Pharmacology & Therapeutics. 63(2). 242–253. 1 indexed citations
4.
Zhou, Jerry, et al.. (2024). Comparison of Gas-sensing Capsule With Wireless Motility Capsule in Motility Disorder Patients. Journal of Neurogastroenterology and Motility. 30(3). 303–312. 7 indexed citations
5.
6.
Varney, Jane, Rebecca Burgell, Mark Morrison, et al.. (2024). 886 EFFICACY OF THE LOW FODMAP DIET FOR GASTROINTESTINAL SYMPTOMS ASSOCIATED WITH ENDOMETRIOSIS - A RANDOMISED CONTROLLED TRIAL. Gastroenterology. 166(5). S–208. 1 indexed citations
7.
Fehily, Sasha R., Chamara Basnayake, Emily K. Wright, et al.. (2024). Probiotics: are they beneficial?. Internal Medicine Journal. 54(6). 861–870. 5 indexed citations
8.
Skvarc, David, Subhadra Evans, Daniel Romano, et al.. (2024). Acceptance and Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress: A Randomized Controlled Trial. The American Journal of Gastroenterology. 120(8). 1839–1851. 3 indexed citations
9.
Yao, Chu K, Emma P. Halmos, Jane G. Muir, et al.. (2024). Review article: Current status and future directions of ingestible electronic devices in gastroenterology. Alimentary Pharmacology & Therapeutics. 59(4). 459–474. 15 indexed citations
10.
Gibson, Peter R., et al.. (2023). Application of a Precision‐Dosing Model to a Real‐World Cohort of Patients on Infliximab Maintenance Therapy: Drug Usage and Cost Analysis. The Journal of Clinical Pharmacology. 64(4). 399–409. 2 indexed citations
11.
Lambell, Kate, Darcy Holt, Frances Milat, et al.. (2023). Accuracy of ultrasound, bioelectrical impedance analysis and anthropometry as point‐of‐care measurements of skeletal muscle mass in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 58(3). 309–321. 10 indexed citations
12.
Yao, Chu K, Jasjot Maggo, James A. St John, et al.. (2022). Comparison of gastrointestinal landmarks using the gas‐sensing capsule and wireless motility capsule. Alimentary Pharmacology & Therapeutics. 56(9). 1337–1348. 27 indexed citations
13.
Gibson, Peter R., Emma P. Halmos, Daniel So, et al.. (2022). Diet as a therapeutic tool in chronic gastrointestinal disorders: Lessons from the FODMAP journey. Journal of Gastroenterology and Hepatology. 37(4). 644–652. 15 indexed citations
14.
Vasudevan, Abhinav, Danny Con, Raphael P. Luber, et al.. (2020). Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 52(7). 1174–1184. 19 indexed citations
15.
Kalantar‐Zadeh, Kourosh, Kyle J. Berean, Rebecca Burgell, Jane G. Muir, & Peter R. Gibson. (2019). Intestinal gases: influence on gut disorders and the role of dietary manipulations. Nature Reviews Gastroenterology & Hepatology. 16(12). 733–747. 153 indexed citations
16.
Porter, Judi, et al.. (2018). Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome—directions for future research. Alimentary Pharmacology & Therapeutics. 49(2). 124–139. 60 indexed citations
17.
Berean, Kyle J., Nam Ha, Jian Zhen Ou, et al.. (2018). The safety and sensitivity of a telemetric capsule to monitor gastrointestinal hydrogen production in vivo in healthy subjects: a pilot trial comparison to concurrent breath analysis. Alimentary Pharmacology & Therapeutics. 48(6). 646–654. 51 indexed citations
18.
Juhász, Angéla, Tatiana Belova, Iris Fischer, et al.. (2018). Genome mapping of seed-borne allergens and immunoresponsive proteins in wheat. Science Advances. 4(8). eaar8602–eaar8602. 105 indexed citations
19.
Ward, Mark G., Lauren Beswick, Gennaro Rosella, et al.. (2017). Intra‐patient variability in adalimumab drug levels within and between cycles in Crohn's disease. Alimentary Pharmacology & Therapeutics. 45(8). 1135–1145. 30 indexed citations
20.
Giorgio, Roberto De, Umberto Volta, & Peter R. Gibson. (2015). Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction?. Gut. 65(1). 169–178. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026